CDSCO extends consent to import drugs with less than 60% till 31st October 2022.

According to the provisions of Rule 31 of the Drugs and Cosmetics Rules, 1945, no drug will be imported unless it complies with the standard of strength, purity, and quality when the drug licensing authority will not allow the import of a drug with a less than 60 percent residual shelf life on the date of import of the drug.

NITI Aayog Launches the National Data & Analytics Platform.

NDAP follows a use-case based approach to ensure that the datasets hosted on the platform are tailored to the needs of data users from government, academia, journalism, civil society, and the private sector. All datasets are standardized to a common schema, which makes it easy to merge datasets and do cross-sectoral analysis.